Regeneron Pharmaceuticals Inc. on Tuesday said its experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized patients with mild-to-moderate COVID-19. When asked whether the company would apply for…

Read more »

The post Regeneron Says its COVID-19 Treatment Improves Symptoms appeared first on Hamodia.

In related news:

  1. EU Agency: Coronavirus Vaccine Possible in About a Year
  2. CDC, States’ Reporting of Virus Test Data Causes Confusion
  3. ANALYSIS: Does Drug Touted by Trump Work on COVID-19?
  4. U.S. Revokes Emergency Use of Malaria Drugs vs. Coronavirus
  5. Moderna Set to Start Final-Stage Vaccine Trial in 30,000 People